Insulinoma with suspected mutant somatostatin receptor expression according to histological examination. [PDF]
Onish S +10 more
europepmc +1 more source
Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells. [PDF]
Nguyen N +11 more
europepmc +1 more source
Correction to: Safety and dosimetry of [<sup>177</sup>Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study. [PDF]
Gaze MN +18 more
europepmc +1 more source
Distribution and calcium signaling function of somatostatin receptor subtypes in rat pituitary. [PDF]
Sivcev S +7 more
europepmc +1 more source
Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal Malignancies. [PDF]
Xue E +20 more
europepmc +1 more source
GLI1-Altered Mesenchymal Tumor with ACTB Fusion and Somatostatin Receptor 2A (SSTR2A) Immunopositivity. [PDF]
Grove J, Geisler DL, Naous R.
europepmc +1 more source
Somatostatin Receptor 2 Negative Pheochromocytoma Masked by Normal Adrenal Gland on Gallium-68 DOTATATE. [PDF]
Park SE +4 more
europepmc +1 more source
[89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors. [PDF]
Sanwick AM +5 more
europepmc +1 more source
Gluteal Muscle Metastasis of Papillary Thyroid Cancer with Increased Somatostatin Receptor Expression in <sup>68</sup>Ga-DOTATATE PET/MRI. [PDF]
Kibar A +6 more
europepmc +1 more source

